Search details
1.
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.
N Engl J Med
; 387(25): 2317-2330, 2022 12 22.
Article
in English
| MEDLINE | ID: mdl-36546624
2.
Nasal Brushing Molecular Endotyping Distinguishes CRSwNP Patients with Better Response to Dupilumab.
J Allergy Clin Immunol
; 2024 Jun 14.
Article
in English
| MEDLINE | ID: mdl-38880251
3.
Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma.
J Allergy Clin Immunol
; 2024 Jan 23.
Article
in English
| MEDLINE | ID: mdl-38272375
4.
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.
J Allergy Clin Immunol
; 2024 Feb 29.
Article
in English
| MEDLINE | ID: mdl-38431226
5.
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.
N Engl J Med
; 385(18): 1656-1668, 2021 10 28.
Article
in English
| MEDLINE | ID: mdl-34706171
6.
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
N Engl J Med
; 385(24): 2230-2240, 2021 12 09.
Article
in English
| MEDLINE | ID: mdl-34879449
7.
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 400(10356): 908-919, 2022 09 17.
Article
in English
| MEDLINE | ID: mdl-36116481
8.
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization.
Clin Exp Allergy
; 53(10): 1020-1030, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37752621
9.
Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma.
Ann Allergy Asthma Immunol
; 131(1): 44-51.e4, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36958470
10.
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
Allergy
; 77(7): 2211-2221, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35034364
11.
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
Allergy
; 77(4): 1231-1244, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34459002
12.
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.
N Engl J Med
; 378(26): 2475-2485, 2018 06 28.
Article
in English
| MEDLINE | ID: mdl-29782224
13.
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.
N Engl J Med
; 378(26): 2486-2496, 2018 06 28.
Article
in English
| MEDLINE | ID: mdl-29782217
14.
Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.
Clin Exp Allergy
; 51(7): 915-931, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34037993
15.
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma.
Ann Allergy Asthma Immunol
; 126(5): 584-592.e1, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33465455
16.
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Lancet
; 394(10209): 1638-1650, 2019 11 02.
Article
in English
| MEDLINE | ID: mdl-31543428
17.
Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis.
Allergy
; 75(1): 148-157, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31306495
18.
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis.
Ann Allergy Asthma Immunol
; 125(5): 565-576.e1, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32474156
19.
Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP.
Rhinology
; 58(1): 10-17, 2020 Feb 01.
Article
in English
| MEDLINE | ID: mdl-31671432
20.
Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis.
Allergy
; 2024 Jun 08.
Article
in English
| MEDLINE | ID: mdl-38850227